Interleukin-1 gene cluster polymorphins and susceptibility to clinical malaria in a Gambian case-control study

European Journal of Human Genetics

Volumn 12, Issue 2, 2004, Pages 132-138

  Walley, Andrew J ^a   Aucan, Christophe ^a   Kwiatkowski, Dominic ^a   Hill, Adrian V S ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Case control; Interleukin 1; Malaria; Polymorphism

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ACUTE PHASE RESPONSE; ARTICLE; CASE CONTROL STUDY; CLUSTER ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC KIT; DISEASE SEVERITY; GAMBIA; GENE CLUSTER; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HAPLOTYPE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALARIA; MALARIA FALCIPARUM; PRIORITY JOURNAL; RESTRICTION MAPPING; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; GAMBIA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-1; MALARIA; MULTIGENE FAMILY; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 1342346046     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201084     Document Type: Article

References (41)

1. Snow RW, Craig MH, Deichmann U, le Sueur D: A preliminary continental risk map for malaria mortality among African children. Parasitol Today 1999; 15: 99-104.
2. Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR: Epidemiology of drug-resistant malaria. Lancet Infect Dis 2002; 2: 209-218.
3. Hougard JM, Fontenille D, Chandre F, Darriet F, Carnevale P, Guillet P: Combating malaria vectors in Africa: current directions of research. Trends Parasitol 2002; 18: 283-286.
4. Hill AV, Allsopp CE, Kwiatkowski D et al: Common west African HLA antigens are associated with protection from severe malaria. Nature 1991; 352: 595-600.
5. Modiano D, Luoni G, Sirima BS et al: Haemoglobin C protects against clinical Plasmodium falciparum malaria. Nature 2001; 414: 305-308.
6. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D: Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508-510.
7. Aitman TJ, Cooper LD, Norsworthy PJ et al: Malaria susceptibility and CD36 mutation. Nature 2000; 405: 1015-1016.
8. Kun JF, Mordmuller B, Lell B, Lehman LG, Luckner D, Kremsner PG: Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria. Lancet 1998; 351: 265-266.
9. Aucan C, Walley AJ, Hennig BJW et al: Interferon-alpha receptor-1 (IFNAR1) variants are associated with protection against cerebral malaria in The Gambia. Genes Immun 2003; 4: 275-282.
10. Jepson A, Sisay-Joof F, Banya W et al: Genetic linkage of mild malaria to the major histocompatibility complex in Gambian children: study of affected sibling pairs. BMJ 1997; 315: 96-97.
11. Rihet P, Traore Y, Abel L, Aucan C, Traore-Leroux T, Fumoux F: Malaria in humans: Plasmodium falciparum blood infection levels are linked to chromosome 5q31-q33. Am J Hum Genet 1998; 63: 498-505.
12. Merriman CR, Pulliam LA, Kampschmidt RF: Comparison of leukocytic pyrogen and leukocytic endogenous mediator. Proc Soc Exp Biol Med 1977; 154: 224-227.
13. Knight JC, Udalova I, Hill AV et al: A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet 1999; 22: 145-150.
14. Stirnadel HA, Stockle M, Felger I, Smith T, Tanner M, Beck HP: Malaria infection and morbidity in infants in relation to genetic polymorphisms in Tanzania. Trop Med Int Health 1999; 4: 187-193.
15. Dunn E, Sims JE, Nicklin MJ, O'Neill LA: Annotating genes with potential roles in the immune system: six new members of the IL-1 family. Trends Immunol 2001; 22: 533-536.
16. Hanada T, Yoshimura A: Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev 2002; 13: 413-421.
17. Sciacca FL, Ferri C, Veglia F et al: IL-1 genes in myasthenia gravis: IL-1A -889 polymorphism associated with sex and age of disease onset. J Neuroimmunol 2002; 122: 94-99.
18. Hutyrova B, Pantelidis P, Drabek J et al: Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002; 165: 148-151.
19. Rainero I, Pinessi L, Salani G et al: A polymorphism in the interleukin-1alpha gene influences the clinical features of migraine. Headache 2002; 42: 337-340.
20. McDowell TL, Symons JA, Ploski R, Forre O, Duff GW: A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis Rheum 1995; 38: 221-228.
21. Machado JC, Pharoah P, Sousa S et al: Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 2001; 121: 823-829.
22. Schulte T, Schols L, Muller T, Woitalla D, Berger K, Kruger R: Polymorphisms in the interleukin-1 alpha and beta genes and the risk for Parkinson's disease. Neurosci Lett 2002; 326: 70-72.
23. Karjalainen J, Nieminen MM, Aromaa A, Klaukka T, Hurme M: The IL-1beta genotype carries asthma susceptibility only in men. J Allergy Clin Immunol 2002; 109: 514-516.
24. Virta M, Hurme M, Helminen M: Increased frequency of interleukin-1beta (-511) allele 2 in febrile seizures. Pediatr Neurol 2002; 26: 192-195.
25. Nemetz A, Kope A, Molnar T et al: Significant differences in the interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in a Hungarian population with inflammatory bowel disease. Scand J Gastroenterol 1999; 34: 175-179.
26. McDevitt MJ, Wang HY, Knobelman C et al: Interleukin-1 genetic association with periodontitis in clinical practice. J Periodontol 2000; 71: 156-163.
27. McGarry F, Neilly J, Anderson N, Sturrock R, Field M: A polymorphism within the interleukin 1 receptor antagonist (IL-1Ra) gene is associated with ankylosing spondylitis. Rheumatology (Oxford) 2001; 40: 1359-1364.
28. Fang XM, Schroder S, Hoeft A, Stuber F: Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis. Crit Care Med 1999; 27: 1330-1334.
29. Ma P, Chen D, Pan J, Du B: Genomic polymorphism within interleukin-1 family cytokines influences the outcome of septic patients. Crit Care Med 2002; 30: 1046-1050.
30. Arnalich F, Lopez-Maderuelo D, Codoceo R et al: Interleukin-1 receptor antagonist gene polymorphism and mortality in patients with severe sepsis. Clin Exp Immunol 2002; 127: 331-336.
31. Tsai FJ, Hsieh YY, Chang CC, Lin CC, Tsai CH: Polymorphisms for interleukin 1 beta exon 5 and interleukin 1 receptor antagonist in Taiwanese children with febrile convulsions. Arch Pediatr Adolesc Med 2002; 156: 545-548.
32. Bellamy R, Ruwende C, Corrah T, McAdam KP, Whittle HC, Hill AV: Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis. Tuberc Lung Dis 1998; 79: 83-89.
33. Touzani O, Boutin H, Chuquet J, Rothwell N: Potential mechanisms of interleukin-1 involvement in cerebral ischaemia. J Neuroimmunol 1999; 100: 203-215.
34. Loddick SA, Rothwell NJ: Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab 1996; 16: 932-940.
35. Touzani O, Boutin H, LeFeuvre R et al: Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptor. J Neurosci 2002; 22: 38-43.
36. Day DJ, Speiser PW, Schulze E et al: Identification of non-amplifying CYP21 genes when using PCR-based diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia (CAH) affected pedigrees. Hum Mol Genet 1996; 5: 2039-2048.
37. Abecasis GR, Cookson WO: GOLD - graphical overview of linkage disequilibrium. Bioinformatics 2000; 16: 182-183.
38. Stephens M, Smith NJ, Donnelly P: A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-989.
39. Gyan B, Goka B, Cvetkovic JT et al: Polymorphisms in interleukin-1beta and interleukin-1 receptor antagonist genes and malaria in Ghanaian children. Scand J Immunol 2002; 56: 619-622.
40. Jurinke C, van den Boom D, Cantor CR, Koster H: The use of MassARRAY technology for high throughput genotyping. Adv Biochem Eng Biotechnol 2002; 77: 57-74.
41. Werner M, Sych M, Herbon N, Illig T, Konig IR, Wist M: Large-scale determination of SNP allele frequencies in DNA pools using MALDI-TOF mass spectrometry. Hum Mutat 2002; 20: 57-64.